Skip to content

Research compound · compound · regulatory review 2026-10-09

Thymulin

Thymic peptide studied with zinc-dependent activity and measured in human blood.

Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock.

Editorial review 2026-10-10. source-curated; clinician review pending.

FDA product
not established
Compounding
not established
Research
investigational
Sport
unknown

What is Thymulin?

Other names in the library: Thymulin 10mg. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: 10 mg. A seller title is a listing. It does not prove the vial matches a paper.

In plain language

Thymulin is listed here as a compound. Thymic peptide studied with zinc-dependent activity and measured in human blood. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use Thymulin or how much to take.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Clinical observation

Thymulin primary study · PMID 2313103

Human blood specimens in an assay-development study.

Reported findings. Assay development and age-group thymulin biomarker observations; not treatment efficacy.

Nonresponse. Nonresponse frequency not established in this excerpt.

Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.

Limits. A measurement study is not a treatment trial and does not show that supplementation improves immunity.

Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Human trial

Nonathymulin in rheumatoid arthritis: two double blind, placebo controlled trials.

Two placebo-controlled rheumatoid-arthritis trials; total sample not verified from abstract.

Reported findings. Selected study arm improved global assessment in 56% versus 17% of placebo participants; four objective measures also improved.

Nonresponse. No clear accompanying immunological changes were reported.

Harms. Abstract describes minimal adverse effects; detailed events and withdrawals require original full-text verification.

Limits. A selected-arm study proportion is not a general success rate. Full-text access failed; do not import secondary withdrawal claims or infer formulation, route or schedule.

Preparation: Synthetic nonathymulin; zinc coordination and equivalence to commercial thymulin unverified. Route: Unspecified in reviewed primary abstract; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Human trial

Nonathymulin treatment of multiple sclerosis: double-blind pilot study.

40 matched patients with active multiple sclerosis and moderate disability; six-month trial and six-month follow-up.

Reported findings. No clinical benefit was detected on the reported disability, ambulation or functional outcomes.

Nonresponse. Disability, ambulation and functional scores did not differ significantly between active and placebo groups.

Harms. No significant side effects were recorded in this small trial; general safety remains unestablished.

Limits. Results apply to this preparation and population. Dose, zinc formulation, funding and conflicts are not established by the reviewed abstract.

Preparation: Synthetic serum thymic factor/nonathymulin; commercial thymulin and zinc formulation equivalence unverified. Route: Subcutaneous in the reported trial; not automatically a route for commercial thymulin.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Clinical observation

An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia

18 adults with androgenetic alopecia,17 men/1 woman, ages35–90; uncontrolled open-label4–10-month observations; blinded image assessment;10 subjects eligible for detailed hair-growth-index analysis.

Reported findings. Intermediate hair increased in the10-subject image subset;11 longer-treated participants showed improved visual scores.

Nonresponse. Whole-group visual score did not improve significantly,p0.07; terminal-hair measures were nonsignificant.

Harms. One transient forehead redness episode reported after sun exposure, abrasion and spray; investigator attributed it to citric-acid buffer, not independently established causation.

Limits. No randomized treatment assignment or untreated comparator; image-side randomization is not clinical randomization. Three participants also used minoxidil and/or finasteride. Variable duration, selected subgroup analyses and small sample limit attribution. Reported13/20 assessor-pooled responses must not be presented as20 distinct participants or population success rate. Paper title/conclusion claims safety/efficacy more strongly than the uncontrolled whole-group null supports. This is zinc-thymulin treatment experience, distinct from nonathymulin trials or zinc correction of endogenous thymulin levels. No indexed lifecycle notice found in bounded exact-title/DOI search; comprehensive publisher lifecycle clearance not established.

Preparation: Author-synthesized pEAKSQGGSN chemically combined with zinc in buffered topical spray; LCMS peptide purity reported above95%. Only this studied zinc complex, not free peptide or an injectable outcome. Route: Topical scalp spray; no injected immune-treatment outcome.

Read original source ↗

Editorial review 2026-10-10. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Compounding

not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.

Research

investigational. Human blood specimens in an assay-development study.

Sport

unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.

Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.

U-100 math for listed Thymulin sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
10 mg1005033.3

Risks and mix-ups already on the record

  • Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
  • No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
  • No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.

People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.

Sources

  1. Thymulin primary study · PMID 2313103 · checked 2026-10-09

Questions people ask

Is Thymulin FDA-approved?

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Does PepBear pick an amount of Thymulin?

The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.

Related cards

Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.

Optional merchant comparison

Where to buy Thymulin

Compare the same identity, formulation and format. Blends, oral products and different variants stay separate. A lower price does not establish product quality or medical suitability.

We earn a commission when you buy through PepStar LLC partner links or codes RICHPEP and PEPBEAR. Merchant listings are separate from the evidence and do not establish product quality or medical suitability.

Other dated listings with incomplete quantity or equivalence verification (1)

Individual listing · equivalence unverified

Thymulin product listings. Prices exclude unverified shipping and tax.
Price / savingsProduct / quantityTerms / availabilityAction
Price unavailableProduct subtotal. Shipping and tax excluded where unverified.Thymulin 10mgLimitless Life NootropicsFormulation not verified · format not verifiedQuantity not verified. No total mg or price per mg.Listed in stock
RICHPEP

Coupon terms unverified. Item eligibility and stacking unverified; no coupon included in this price.

Dates and offer terms

Price verified: not verified. Quantity verified: not verified.

Listing observed: Oct 9, 2026. Confirm availability with the seller.

Item terms verified: not verified. Eligibility: unknown. Stacking: unknown.

Shipping: not verified; seller charges excluded. Tax: not verified; excluded.

View product: Thymulin 10mg at Limitless Life Nootropics (opens new tab)Exact merchant listingPartner customer link (opens new tab)Opens the partner referral page. Choose the exact product there; this is separate from the listing above.
Listing source

listing · Oct 9, 2026